Navigation Links
Masimo to Present at the 28th Annual J.P. Morgan Healthcare Conference
Date:12/23/2009

IRVINE, Calif., Dec. 23 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that its management is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 11, 2010, at 2:00 p.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.

About Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET® provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET® Pulse CO-Oximetry(TM), a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), PVI® and acoustic respiration rate (RRa), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.


    Masimo Corporation
    Investor Contact:                         Media Contact:
    Sheree Aronson                            Dana Banks
    Vice President, Investor Relations        Manager, Public Relations
    Masimo Corporation                        Masimo Corporation
    (949) 297-7043                            (949) 297-7348
    saronson@masimo.com                       dbanks@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, RRa, Radical-7, Rad-87, Rad-57,Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.

SOURCE Masimo Corporation


'/>"/>
SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants
2. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
3. Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress
4. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
5. New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood
6. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
7. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
8. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
9. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
10. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
11. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Medical Imaging body ... performed to reveal the internal structures hidden by the ... condition. It plays a vital role not only in ... is taken into consideration during the follow-up of various ... ultrasound, CT, and MRI. For the diagnosis and treatment ...
(Date:2/23/2017)... 22, 2017 Summary Provides ... deals and agreements entered into by the worlds ... http://www.reportlinker.com/p03605669-summary/view-report.html Description The Global Non-Hodgkin ... provides understanding and access to partnering deals and ... companies. - Trends in partnering deals ...
(Date:2/23/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and ... its fourth quarter and full year 2016 financial results ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... can be obtained as follows: Thursday, March ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The ... eligibility requirements effective with the April 2017 testing period. NACCM, a nonprofit organization, ... Care Manager Certified (CMC) exam is periodically re-calibrated to ensure that newly certified ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a ... skipping doses or not filling a prescription because they could not afford to ... problems getting medications were 30-60%*. At the same time, hospitals, pharmacies, ...
(Date:2/22/2017)... ... February 22, 2017 , ... THR ... “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified CBD product utilizes Quicksilver ... the bloodstream. Far outpacing the absorption speed of all other products, ...
(Date:2/22/2017)... ... February 22, 2017 , ... The ... Insights to help small practices in Delaware, New Jersey, Pennsylvania and West Virginia ... Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). , This technical ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... launched a new media platform connecting healthcare technology professionals and other key stakeholders ... by a quarterly publication starting on March 1, announced Michael J. Hennessy, Jr., ...
Breaking Medicine News(10 mins):